本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Oric Pharmaceuticals Inc.

9.24
-0.3900-4.05%
盘后9.06-0.1800-1.95%19:46 EDT
成交量:105.01万
成交额:970.88万
市值:7.87亿
市盈率:-4.91
高:9.66
开:9.64
低:9.03
收:9.63
52周最高:14.67
52周最低:3.90
股本:8,521.84万
流通股本:5,545.50万
量比:1.37
换手率:1.89%
股息:- -
股息率:- -
每股收益(TTM):-1.8805
每股收益(LYR):-1.8335
净资产收益率:-48.45%
总资产收益率:-30.87%
市净率:3.58
市盈率(LYR):-5.04

数据加载中...

2025/06/18

SEC问询函

Form CORRESP - Correspondence
2025/06/13

重要事件披露

Form 8-K - Current report
2025/06/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/28

重要事件披露

Form 8-K - Current report
2025/05/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/05

重要事件披露

Form 8-K - Current report
2025/03/20

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/14

重要事件披露

Form 8-K - Current report
2025/02/25

重要事件披露

Form 8-K - Current report
2025/02/19

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/19

重要事件披露

Form 8-K - Current report
2025/01/13

重要事件披露

Form 8-K - Current report
2024/12/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]